Welcome to LookChem.com Sign In|Join Free
  • or
Benzenemethanamine, 4-(1,1-dimethylethoxy)-.alpha.-methyl- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

143589-82-6

Post Buying Request

143589-82-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

143589-82-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 143589-82-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,3,5,8 and 9 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 143589-82:
(8*1)+(7*4)+(6*3)+(5*5)+(4*8)+(3*9)+(2*8)+(1*2)=156
156 % 10 = 6
So 143589-82-6 is a valid CAS Registry Number.

143589-82-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-{4-[(2-Methyl-2-propanyl)oxy]phenyl}ethanamine

1.2 Other means of identification

Product number -
Other names 1-(4-tert-butoxycarbonylaminophenyl)piperazine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:143589-82-6 SDS

143589-82-6Relevant academic research and scientific papers

METHOD FOR PRODUCING OPTICALLY ACTIVE AMINOALKYLPHENOLS

-

Page/Page column 26, (2008/06/13)

The invention relates to a method for the enantioselective N-acylation of aminoalkylphenols, and to a method for producing enantiomer-pure compounds of formulae (I-S) and/or (I-R).

HIV PROTEASE INHIBITORS

-

, (2008/06/13)

Peptide mimics, having a constrained peptide backbone conformation, are HIV protease inhibitors. A compound of this invention is, for example, 3-Benzyl-5(alaninyl-1-aminoethyl)-2,3,6,7-tetrahydro-N-azepinyl-2-propionyl-valinyl-valinyl methyl ester.

A novel constrained reduced-amide inhibitor of HIV-1 protease derived from the sequential incorporation of γ-turn mimetics into a model substrate

Newlander,Callahan,Moore,Tomaszek Jr.,Huffman

, p. 2321 - 2331 (2007/10/02)

C7 mimetics, designed to lock three amino acid residues of a peptide chain into a γ-turn conformation, were introduced sequentially between the P3 to P2' positions of a model HIV-1 protease substrate I (resulting in compou

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 143589-82-6